» Articles » PMID: 35012007

Cognitive Impairment in People with Epilepsy

Overview
Journal J Clin Med
Specialty General Medicine
Date 2022 Jan 11
PMID 35012007
Authors
Affiliations
Soon will be listed here.
Abstract

People with epilepsy frequently have cognitive impairment. The majority of cognitive problems is influenced by a variety of interlinked factors, including the early onset of epilepsy and the frequency, intensity and duration of seizures, along with the anti-epileptic drug treatment. With a systematic review, we investigate significant factors about the cognitive impairment in epilepsy. Most cognitive problems in adult people with epilepsy include memory, attention and executive function deficits. However, which cognitive area is mainly affected highly depends on the location of epileptic activity. Moreover, modifications in signalling pathways and neuronal networks have an essential role in both the pathophysiology of epilepsy and in the mechanism responsible for cognitive impairment. Additionally, studies have shown that the use of polytherapy in the treatment of epilepsy with anti-epileptic drugs (AEDs) heightens the risk for cognitive impairment. It can be challenging to distinguish the contribution of each factor, because they are often closely intertwined.

Citing Articles

Pirfenidone regulates seizures through the HMGB1/TLR4 axis to improve cognitive functions and modulate oxidative stress and neurotransmitters in PTZ-induced kindling in mice.

Dahalia M, Gupta S, Majid H, Vohora D, Nidhi Front Pharmacol. 2025; 15:1528032.

PMID: 39911825 PMC: 11794304. DOI: 10.3389/fphar.2024.1528032.


The Anticonvulsant Effect of Nonsteroidal Anti-Inflammatory Drug, Fenoprofen, in Pentylenetetrazole-Induced Epileptic Rats: Behavioral, Histological, and Biochemical Evidence.

Rahimi-Tesiye M, Rajabi-Maham H, Azizi V, Hosseini A Pharmacol Res Perspect. 2025; 13(1):e70072.

PMID: 39907374 PMC: 11795576. DOI: 10.1002/prp2.70072.


Astrocytic Acid-Sensing Ion Channel 1a Contributes to the Development of Epileptic Cognitive Impairment.

Li W, Zhou H, Li X, Hu G, Wei D Biomolecules. 2025; 15(1).

PMID: 39858536 PMC: 11764220. DOI: 10.3390/biom15010142.


Analyzing the potential of neuronal pentraxin 2 as a biomarker in neurological disorders: A literature review.

Ansari U, Wen J, Syed B, Nadora D, Sedighi R, Nadora D AIMS Neurosci. 2025; 11(4):505-519.

PMID: 39801792 PMC: 11712228. DOI: 10.3934/Neuroscience.2024031.


A Comprehensive Review of Recent Trends in Surgical Approaches for Epilepsy Management.

Sabzvari T, Aflahe Iqbal M, Ranganatha A, Daher J, Freire I, Shamsi S Cureus. 2024; 16(10):e71715.

PMID: 39553057 PMC: 11568833. DOI: 10.7759/cureus.71715.


References
1.
Han T, Qin Y, Mou C, Wang M, Jiang M, Liu B . Seizure induced synaptic plasticity alteration in hippocampus is mediated by IL-1β receptor through PI3K/Akt pathway. Am J Transl Res. 2016; 8(10):4499-4509. PMC: 5095344. View

2.
Cooke S, Bliss T . Plasticity in the human central nervous system. Brain. 2006; 129(Pt 7):1659-73. DOI: 10.1093/brain/awl082. View

3.
Staley K . Molecular mechanisms of epilepsy. Nat Neurosci. 2015; 18(3):367-72. PMC: 4409128. DOI: 10.1038/nn.3947. View

4.
Nickels K, Wirrell E . Cognitive and Social Outcomes of Epileptic Encephalopathies. Semin Pediatr Neurol. 2017; 24(4):264-275. DOI: 10.1016/j.spen.2017.10.001. View

5.
Taylor J, Kolamunnage-Dona R, Marson A, Smith P, Aldenkamp A, Baker G . Patients with epilepsy: cognitively compromised before the start of antiepileptic drug treatment?. Epilepsia. 2009; 51(1):48-56. DOI: 10.1111/j.1528-1167.2009.02195.x. View